Skip to content
Download
Why a 25-cent pill is being sold to cancer patients for nearly $1,000

Why a 25-cent pill is being sold to cancer patients for nearly $1,000

Apple News In Conversation
May 29, 2025 27 min
Open in Clue

About this episode

<p>When <em>ProPublica</em> health-care reporter David Armstrong was diagnosed with a rare blood cancer, he began taking a lifesaving drug called Revlimid. When he learned that each pill of this medication is sold for nearly $1,000 but costs drug companies only cents to make, he went on a quest to uncover the reasons behind its shocking price tag. Armstrong sat down with <em>Apple News In Conversation</em> host Shumita Basu to talk about his <a href="https://apple.news/ATKPlgJFmSV6qNJCo0bjbVA" target="_blank" rel="noopener noreferrer">investigation</a> into Revlimid&rsquo;s origins and what it reveals about prescription-drug pricing in America.</p>

Listen to this episode in English to learn English

Podcast episodes are one of the highest-density ways to absorb English at native pace. Why a 25-cent pill is being sold to cancer patients for nearly $1,000 from Apple News In Conversation gives you natural dialogue, unscripted speech, and vocabulary that actually appears in real conversations.

In the Clue app, every word in the transcript is tappable. Tap an unknown word, see the translation in your language instantly, and keep listening without breaking flow.

Episodes to Learn English

More podcasts in English